Sequenom Q4 Revenue Down 24 Percent | GenomeWeb

This story has been updated to provide comments from Sequenom management made during a conference call with investors.

NEW YORK (GenomeWeb) – Sequenom's fourth quarter 2015 revenues were down 24 percent compared to the fourth quarter 2014, the company reported after the close of the market on Wednesday.

The San Diego, California-based molecular diagnostic company reported total Q4 revenues of $27.8 million compared to $36.8 million in Q4 2014. It missed analysts' average estimate of $28.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.

Sponsored by

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Sponsored by

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.